L, S. D., MB, M., C, A., MR, G., Q, M., P, D. M., . . . R, C. (2026). Codelivery of Doxorubicin and Carvacrol via a β-Cyclodextrin-Hyaluronic Acid Nanogel System for Targeted and Stimuli-Responsive Anticancer Therapy. ACS applied bio materials, 9(7), 3257. https://doi.org/10.1021/acsabm.5c02196
Chicago Style (17th ed.) CitationL, Sathi Devi, Morelli MB, Amantini C, Gigliobianco MR, Ma Q, Di Martino P, Casadidio C, and Censi R. "Codelivery of Doxorubicin and Carvacrol via a β-Cyclodextrin-Hyaluronic Acid Nanogel System for Targeted and Stimuli-Responsive Anticancer Therapy." ACS Applied Bio Materials 9, no. 7 (2026): 3257. https://doi.org/10.1021/acsabm.5c02196.
MLA (9th ed.) CitationL, Sathi Devi, et al. "Codelivery of Doxorubicin and Carvacrol via a β-Cyclodextrin-Hyaluronic Acid Nanogel System for Targeted and Stimuli-Responsive Anticancer Therapy." ACS Applied Bio Materials, vol. 9, no. 7, 2026, p. 3257, https://doi.org/10.1021/acsabm.5c02196.